Bio-Rad Laboratories (BIO.B)

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

O preço da ação Bio-Rad Laboratories, Inc. Class B (BIO.B) after-hours hoje é de $ 261,83, refletindo uma movimentação de +1,86% after-hours desde que o mercado fechou. A capitalização de mercado da empresa é de $ 7,07 bi, com um volume comercial diário de $ 1,00 ações. O preço de fechamento anterior foi $ 257,05.

Vamos começar? Siga os passos abaixo ou leia nosso guia sobre como comprar Bio-Rad Laboratories ações na Kraken a partir de US$ 10.